Multiple Ascending Dose Study of SPC4955 in Healthy Subjects

NCT01365663 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: SPC4955
DRUG: SPC4955
DRUG: SPC4955
DRUG: SPC4955
DRUG: SPC4955
DRUG: Saline 0.9%

Sponsor

Santaris Pharma A/S